UBS Group’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-55
| Closed | -$2K | – | 7500 |
|
|
2019
Q4 | $2K | Sell |
55
-7
| -11% | -$255 | ﹤0.01% | 6822 |
|
|
2019
Q3 | $1K | Sell |
62
-2,128
| -97% | -$34.3K | ﹤0.01% | 6946 |
|
|
2019
Q2 | $57K | Buy |
+2,190
| New | +$57K | ﹤0.01% | 4954 |
|
|
2018
Q4 | – | Sell |
-3,269
| Closed | -$144K | – | 7373 |
|
|
2018
Q3 | $144K | Buy |
3,269
+1,224
| +60% | +$53.9K | ﹤0.01% | 4442 |
|
|
2018
Q2 | $68K | Buy |
+2,045
| New | +$68K | ﹤0.01% | 4867 |
|
|
2018
Q1 | – | Sell |
-3,003
| Closed | -$101K | – | 7210 |
|
|
2017
Q4 | $101K | Buy |
+3,003
| New | +$101K | ﹤0.01% | 4412 |
|
|
2017
Q2 | – | Sell |
-2,651
| Closed | -$73K | – | 7003 |
|
|
2017
Q1 | $73K | Buy |
+2,651
| New | +$73K | ﹤0.01% | 4390 |
|
|
2016
Q4 | – | Sell |
-2,622
| Closed | -$76K | – | 7012 |
|
|
2016
Q3 | $76K | Buy |
2,622
+1,666
| +174% | +$48.3K | ﹤0.01% | 4326 |
|
|
2016
Q2 | $20K | Sell |
956
-4,969
| -84% | -$104K | ﹤0.01% | 5441 |
|
|
2016
Q1 | $140K | Buy |
5,925
+5,385
| +997% | +$127K | ﹤0.01% | 4011 |
|
|
2015
Q4 | $31K | Buy |
540
+150
| +38% | +$8.61K | ﹤0.01% | 5179 |
|
|
2015
Q3 | $17K | Buy |
+390
| New | +$17K | ﹤0.01% | 5589 |
|